Deutsche Bank have long recommended (buy or hold) DXC. From $90 to the current buy-back inflated $26. Clearly the commercial relationship is clouding objectivity. Either that or the long term analyst (BK) is an id--t. A quick read of this site, would give any current or potential, investor, employee or client enough insight to see DXC is simply a rotting carcass being fed off by the executives. The fish does rot from the head and the poor employees sit in the stinking mess. Best advice - leave the organisation. There are few worse employers than DXC; although I am hard pressed to think who they are
4 replies (most recent on top)
Not so sure the analyst is at fault. The bank would find it difficult to down rate a supplier without the supplier pushing back. MrShouty and MikeMk1 are likely to be screamers. Glass-Steagall was brought in because of the conflicts of interest. Watch The Big Short to see how investment banks and rating agencies work in the interest of themselves. When the analyst is reviewed it would be known that his rating has been consistently wrong since DXC formed. And DXC performance relative to benchmark would be horrendous. Any analyst worth their weight would be saying put your money into Accenture (almost up 300% in past 5 years) over DXC (worth 50% of what it was 5 years ago and about 1/5 of what it was at its peak). Clients who invested on the analyst recommendation would be livid at the capital loss, weak dividends and the buy back prop up. So the bank are probably saying one thing but doing another. SEC should look into this.
Hand in glove cahoots with no deep understanding of the company. Deutsche yearly revenue is not that great - so doubt that makes any impact on the coverage. One d-mb analyst.
Hand in glove cahoots - with no deep understanding of the company. The Deutsche yearly revenue is not that great, so doubt it makes any influence.
Deutsche Bank is pretty big and it covers alot of companies. Likely the anaylist is the one you want to fault.